CY1114334T1 - SAS TANNATE OF RASAGILINE - Google Patents

SAS TANNATE OF RASAGILINE

Info

Publication number
CY1114334T1
CY1114334T1 CY20131100377T CY131100377T CY1114334T1 CY 1114334 T1 CY1114334 T1 CY 1114334T1 CY 20131100377 T CY20131100377 T CY 20131100377T CY 131100377 T CY131100377 T CY 131100377T CY 1114334 T1 CY1114334 T1 CY 1114334T1
Authority
CY
Cyprus
Prior art keywords
tannate
rasagiline
sas
compositions
manufacture
Prior art date
Application number
CY20131100377T
Other languages
Greek (el)
Inventor
Anton Frenkel
Tamas Koltai
Original Assignee
Teva Pharmaceutical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07867741A external-priority patent/EP2101570B1/en
Application filed by Teva Pharmaceutical Industries, Ltd. filed Critical Teva Pharmaceutical Industries, Ltd.
Publication of CY1114334T1 publication Critical patent/CY1114334T1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Η εφεύρεση του θέματος παρέχει rasagiline tannate, συνθέσεις και μία διαδικασία κατασκευής αυτού.The subject invention provides rasagiline tannate, compositions and a process for its manufacture.

CY20131100377T 2006-12-14 2013-05-10 SAS TANNATE OF RASAGILINE CY1114334T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87503806A 2006-12-14 2006-12-14
EP07867741A EP2101570B1 (en) 2006-12-14 2007-12-13 Tannate salt of rasagiline

Publications (1)

Publication Number Publication Date
CY1114334T1 true CY1114334T1 (en) 2016-08-31

Family

ID=58436511

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100377T CY1114334T1 (en) 2006-12-14 2013-05-10 SAS TANNATE OF RASAGILINE

Country Status (1)

Country Link
CY (1) CY1114334T1 (en)

Similar Documents

Publication Publication Date Title
HK1129277A1 (en) Tannate salt of rasagiline
CY1122330T1 (en) COMPOSITIONS OF NERATINIB MILEINIC TABLETS
NO20083147L (en) Anti-OX40L antibodies and methods for their use
NO20083397L (en) Anti-EphB4 antibodies and methods for their use
CY1117615T1 (en) THEIAZOLIS SULFONAMIDIS AND OXAZOLIS COMPOUNDS
EA200702643A1 (en) TWEAK ANTIBODIES
NO20090047L (en) Anti-DLL4 antibodies and methods for their use
DK2101569T3 (en) Crystalline solid rasagiline base
EA200900781A1 (en) 4-PHENYPYRANE-3,5-DIONA, 4-PHENYLTIOPYRANE-3,5-DIONA AND CYCLOHEXANTHRION, AS NEW HERBICIDES
EA200971068A1 (en) TRIAZOLYLAMINOPYRIMIDINE COMPOUNDS
CO6450665A2 (en) ANTI-FGFR3 ANTIBODIES AND METHODS THAT USE THEM
CL2008000822A1 (en) Method for the treatment of obesity using a sglt2 inhibitor.
NO20080246L (en) Anti-IGF1R-antistofformuleringer
MX2009012625A (en) Methods of treating, diagnosing and detecting fgf21-associated disorders.
ATE526318T1 (en) FARNESOID-X RECEPTOR AGONISTS
CY1115651T1 (en) METHOD FOR PREPARATION (1R, 2R) -3- (3-DIMETHYL-1-ETHYL-2-Methyl-propyl) -phenol
CY1114690T1 (en) NRR NOTCH1 COTTAGES AND METHODS OF USE OF THESE
CO6220968A2 (en) HETEROCICLIC INHIBITORS OF THE ASPARTIL PROTEASA
ATE554105T1 (en) ALTERED ANTIBODIES
CY1115871T1 (en) METHODS FOR TREATMENT OF URINARY ARTHRITIS
NO20090879L (en) Titanium dioxide-containing composite
NO20083593L (en) Anti-EphrinB2 antibodies and methods for their use
NO20083153L (en) Chemical connections
EA201270049A1 (en) DESIGNED PHTHALASINE ANTAGONISTS WAYS HEDGEHOG
BRPI0717822A2 (en) COMPOUND, COMPOUND MANUFACTURING PROCESS OF FORMULA I, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND / OR PROPHYLAXY OF DISEASES WHICH ARE ASSOCIATED WITH THE MODULATION OF CB2 RECEPTORS AND USE OF COMPOUND.